Exclusive

Publication

Byline

Regaal Resources Ltd. debuts with 39.01% premium at Rs 141.80

India, Aug. 20 -- Regaal Resources Ltd. makes a strong debut on the bourses with scrip got listed at Rs 141.80 on the Bombay Stock Exchange, a 39.01 per cent premium to its issue price of Rs 102.00. O... Read More


Rupee slips 3 paise to 87.16 against US dollar in early trade

India, Aug. 20 -- The rupee edged lower by 3 paise to 87.16 against the US dollar in early trade on Wednesday, pressured by weak Asian currencies and a negative trend in domestic equities. Traders s... Read More


CCI approves Micro Life Sciences stake deal

India, Aug. 20 -- The Competition Commission of India (CCI) has cleared the proposed acquisition of shares in Micro Life Sciences by Platinum Jasmine A 2018 Trust, an entity backed by the Abu Dhabi In... Read More


Satin Finserv appoints Pramod Marar as CEO to spearhead Green Finance Vision

India, Aug. 20 -- Satin Finserv Limited (SFL), a wholly owned subsidiary of Satin Creditcare Network Limited (SCNL), has appointed Mr. Pramod Marar as Chief Executive Officer to lead its green finance... Read More


Lupin launches Bosentan Tablets for Oral Suspension in US with 180-day exclusivity

India, Aug. 20 -- Global pharma company Lupin Limited announced the launch of Bosentan Tablets for Oral Suspension, 32 mg, in the United States. The launch follows USFDA approval granted to Lupin's al... Read More


PG Electroplast and PAX India Forge Strategic Manufacturing Partnership

India, Aug. 20 -- PG Electroplast Limited (PGEL), one of India's leading Electronic Manufacturing Services (EMS) providers, has signed a definitive agreement with PAX India, a subsidiary of PAX Global... Read More


Dr. Lal PathLabs Introduces AI-Powered Cancer Diagnosis in India

India, Aug. 20 -- New Delhi, August 20, 2025 – Dr. Lal PathLabs (DLPL) has become the first laboratory in India to integrate a deep learning-based AI module for detecting lymph node metastasis, ... Read More


NATCO launches generic Bosentan tablets in US with 180-day exclusivity

India, Aug. 20 -- NATCO Pharma Ltd has launched Bosentan Tablets for Oral Suspension (32 mg), a generic version of Tracleer® by Actelion Pharmaceuticals, in the US market. The product will be mark... Read More


Vishnu Chemicals subsidiary begins commercial production of Strontium Carbonate

India, Aug. 20 -- Vishnu Chemicals Ltd informed that its wholly owned subsidiary, Vishnu Strontium Private Limited, has commenced commercial production of Strontium Carbonate at its Atchutapuram unit ... Read More


Acknit Industries Lt has declared 15% Final dividend for the financial year March 2025

India, Aug. 20 -- Acknit Industries Ltd. on Wednesday, 28 May 2025, has announced Final dividend of 15 percent on Equity Share, to its shareholders holding shares on the register on Monday, 08 Septemb... Read More